Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(9):1007-1014.
doi: 10.2174/0118715303249690231006114308.

Insights on the Correlation between Mitochondrial Dysfunction and the Progression of Parkinson's Disease

Prashant Chauhan  1 , Pratibha Pandey  1 , Fahad Khan  1 , Ramish Maqsood  1
Affiliations
Review

Insights on the Correlation between Mitochondrial Dysfunction and the Progression of Parkinson's Disease

Prashant Chauhan et al. Endocr Metab Immune Disord Drug Targets. 2024.

Abstract

The aetiology of a progressive neuronal Parkinson's disease has been discussed in several studies. However, due to the multiple risk factors involved in its development, such as environmental toxicity, parental inheritance, misfolding of protein, ageing, generation of reactive oxygen species, degradation of dopaminergic neurons, formation of neurotoxins, mitochondria dysfunction, and genetic mutations, its mechanism of involvement is still discernible. Therefore, this study aimed to review the processes or systems that are crucially implicated in the conversion of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) into its lethal form, which directly blockades the performance of mitochondria, leading to the formation of oxidative stress in the dopaminergic neurons of substantia nigra pars compacta (SNpc) and resulting in the progression of an incurable Parkinson's disease. This review also comprises an overview of the mutated genes that are frequently associated with mitochondrial dysfunction and the progression of Parkinson's disease. Altogether, this review would help future researchers to develop an efficient therapeutic approach for the management of Parkinson's disease via identifying potent prognostic and diagnostic biomarkers.

Keywords: Parkinson’s disease; biomarker; dopaminergic neurons; mitochondrial dysfunction; neurodegeneration; neurotoxins..

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Nguyen M.; Wong Y.C.; Ysselstein D.; Severino A.; Krainc D.; Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease. Trends Neurosci 2019,42(2),140-149 - DOI - PubMed
    1. Maruyama W.; Strolin-Benedetti M.; Naoi M.; N-methyl(R)] salsolinol and a neutral N-methyltransferase as pathogenic factors in Parkinson’s disease. Neurobiology 2000,8(1),55-68 - PubMed
    1. Tozzi A.; Sciaccaluga M.; Loffredo V.; Brain A.M.; Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit. Brain 2021,144(11),3477-3491
    1. Marchetti B.; Giachino C.; Tirolo C.; Cell M.S.A.; “Reframing” dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications. Aging Cell 2022,21(4),e13575
    1. Wise R.; Wagener A.; Fietzek U.; Disease T.K.; Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson’s disease and Neurodegeneration with Brain Iron Accumulation disorders. Neurobiol Dis 2022,175,105920

Substances